{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:11:52Z","timestamp":1792599112465,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.canlet.2023.216596","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T12:26:31Z","timestamp":1702470391000},"page":"216596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3\u03b2\/TCF7\/MMP9 pathway and synergies with capecitabine"],"prefix":"10.1016","volume":"582","author":[{"given":"Xiaoshuo","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9568-0031","authenticated-orcid":false,"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2023.216596_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.canlet.2023.216596_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"issue":"10207","key":"10.1016\/j.canlet.2023.216596_bib3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.canlet.2023.216596_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1078155221989420","article-title":"Adverse reactions and adherence to capecitabine: a prospective study in patients with gastrointestinal cancer","volume":"28","author":"Visacri","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.canlet.2023.216596_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1751-2980.13079","article-title":"Chinese consensus on prevention of colorectal neoplasia (2021, Shanghai)","volume":"23","year":"2022","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.canlet.2023.216596_bib6","article-title":"Efficacy and safety of systemic treatments among colorectal cancer patients: a network meta-analysis of randomized controlled trials","volume":"11","author":"Hoang","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2023.216596_bib7","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.canlet.2023.216596_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: a potential natural anticancer drug","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2023.216596_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153932","article-title":"Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways","volume":"98","author":"Yu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2023.216596_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.768879","article-title":"Dihydroartemisinin suppresses the tumorigenesis and cycle progression of colorectal cancer by targeting CDK1\/CCNB1\/PLK1 signaling","volume":"11","author":"Yi","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2023.216596_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2023.216596_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118006","article-title":"The genetic factors associated with Wnt signaling pathway in colorectal cancer","volume":"256","author":"Aghabozorgi","year":"2020","journal-title":"Life Sci."},{"issue":"19","key":"10.1016\/j.canlet.2023.216596_bib13","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1046\/j.1432-1327.2000.01673.x","article-title":"Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5\/p25","volume":"267","author":"Leost","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.canlet.2023.216596_bib14","article-title":"Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment","volume":"2011","author":"Martinez","year":"2011","journal-title":"Int. J. Alzheimer's Dis."},{"issue":"4","key":"10.1016\/j.canlet.2023.216596_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40263-014-0152-8","article-title":"Role of lithium augmentation in the management of major depressive disorder","volume":"28","author":"Bauer","year":"2014","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.canlet.2023.216596_bib16","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1038\/oncsis.2017.84","article-title":"Combination curcumin and (-)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK\/STAT3\/IL-8 pathway","volume":"6","author":"Jin","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2023.216596_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01998","article-title":"Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6","volume":"3","author":"Stamos","year":"2014","journal-title":"Elife"},{"issue":"16","key":"10.1016\/j.canlet.2023.216596_bib18","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.canlet.2023.216596_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3892\/or.2016.4902","article-title":"Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model","volume":"36","author":"Iwai","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2023.216596_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biocel.2019.02.010","article-title":"Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer","volume":"110","author":"Parizadeh","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2023.216596_bib21","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/ptr.7492","article-title":"Pull the plug: anti-angiogenesis potential of natural products in gastrointestinal cancer therapy","author":"Ai","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.canlet.2023.216596_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4615-4221-6_9","article-title":"Signal transduction and transcriptional regulation of angiogenesis","volume":"476","author":"Sato","year":"2000","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3 Pt 1","key":"10.1016\/j.canlet.2023.216596_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02624456","article-title":"Spontaneous transformation and immortalization of human endothelial cells","volume":"26","author":"Takahashi","year":"1990","journal-title":"In Vitro Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.canlet.2023.216596_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/cells8050494","article-title":"Improved antitumor efficacy of combined vaccine based on the induced HUVECs and DC-CT26 against colorectal carcinoma","volume":"8","author":"Zhang","year":"2019","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.canlet.2023.216596_bib25","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/annonc\/mdx416","article-title":"Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors","volume":"28","author":"Izumchenko","year":"2017","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2023.216596_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/ijc.IJC_618_19","article-title":"Efficacy and safety of capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer: an observational study from a tertiary cancer center in South India","volume":"59","author":"Kalidindi","year":"2022","journal-title":"Indian J. Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2023.216596_bib27","first-page":"627","article-title":"Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 (vol 7, pg 627, 2022)","volume":"7","author":"Jakovljevic","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2023.216596_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev-immunol-082019-081656","article-title":"Cruel to Be kind: epithelial, microbial, and immune cell interactions in gastrointestinal cancers","volume":"38","author":"Shalapour","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2023.216596_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8(+) T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2023.216596_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.17219\/acem\/130356","article-title":"Interleukin 6: biological significance and role in inflammatory bowel diseases","volume":"30","author":"Pawlowska-Kamieniak","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.canlet.2023.216596_bib31","first-page":"184","article-title":"Drug resistance, predictive markers and pharmacogenomics in colorectal cancer","volume":"1766","author":"Longley","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.canlet.2023.216596_bib32","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4103\/jcrt.JCRT_1123_19","volume":"17","author":"Aoyama","year":"2021","journal-title":"J. Cancer Res. Therapeut."},{"issue":"12","key":"10.1016\/j.canlet.2023.216596_bib33","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s10147-020-01757-z","article-title":"FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study","volume":"25","author":"de Albuquerque Ribeiro Gondinho","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2023.216596_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41419-021-04247-w","article-title":"Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level","volume":"12","author":"Hu","year":"2021","journal-title":"Cell. Death Dis."},{"issue":"11\u201312","key":"10.1016\/j.canlet.2023.216596_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1101\/gad.348226.120","article-title":"Genetic and biological hallmarks of colorectal cancer","volume":"35","author":"Li","year":"2021","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.canlet.2023.216596_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000510609","article-title":"High expression of MMP-9 in primary tumors and high preoperative MPO in serum predict improved prognosis in colorectal cancer with operable liver metastases","volume":"99","author":"Peltonen","year":"2021","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.canlet.2023.216596_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.immuni.2006.12.007","article-title":"Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration","volume":"26","author":"Wu","year":"2007","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.canlet.2023.216596_bib38","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2174\/1871520620666201001104928","article-title":"Downregulation of GPR4 and TCF7 promotes apoptosis and inhibits growth and invasion of ovarian cancer cells","volume":"21","author":"Bai","year":"2021","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"4","key":"10.1016\/j.canlet.2023.216596_bib39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/1440-1681.13461","article-title":"Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg\/Th17 balance","volume":"48","author":"Chen","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7787","key":"10.1016\/j.canlet.2023.216596_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2023.216596_bib41","doi-asserted-by":"crossref","first-page":"737849","DOI":"10.3389\/fimmu.2021.737849","article-title":"Capecitabine can induce T cell apoptosis: a potential immunosuppressive agent with anti-cancer effect","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2023.216596_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2023.216596_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1809947","article-title":"beta-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer","volume":"9","author":"Wang","year":"2020","journal-title":"OncoImmunology"},{"issue":"7","key":"10.1016\/j.canlet.2023.216596_bib44","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"issue":"24","key":"10.1016\/j.canlet.2023.216596_bib45","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1200\/JCO.2017.72.3569","article-title":"Timing of aspirin and other nonsteroidal anti-inflammatory drug use among patients with colorectal cancer in relation to tumor markers and survival","volume":"35","author":"Hua","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.canlet.2023.216596_bib46","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.7150\/thno.55939","article-title":"Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer","volume":"11","author":"Bai","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.canlet.2023.216596_bib47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00280-020-04053-9","article-title":"SNPs in the COX-2\/PGES\/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome","volume":"85","author":"Liao","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.canlet.2023.216596_bib48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2567.2002.01461.x","article-title":"Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes","volume":"106","author":"Melgar","year":"2002","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.canlet.2023.216596_bib49","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/modpathol.2017.40","article-title":"Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns","volume":"30","author":"Vanoli","year":"2017","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.canlet.2023.216596_bib50","first-page":"4417","article-title":"First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers","volume":"31","author":"Jansen","year":"2011","journal-title":"Anticancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523005475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523005475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:16:40Z","timestamp":1759594600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523005475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":50,"alternative-id":["S0304383523005475"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216596","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3\u03b2\/TCF7\/MMP9 pathway and synergies with capecitabine","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216596"}}